Imiquimod and Superficial Skin Cancers

September 2005 | Volume 4 | Issue 5 | Original Article | 598 | Copyright © 2005

Mark Naylor MD

Abstract

Topical imiquimod has opened an entirely new area of dermatology that previously did not exist: medical therapy for skin cancers. While surgery will continue to play a vital role in treating more aggressive tumors and in patients who may not be imiquimod candidates, the availability of a viable medical therapy that can be used independently or in combination with other modalities will considerably enhance our ability to treat skin cancer successfully.

Purchase Original Article

Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.

Download the original manuscript as it was published in the JDD.

Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.

To get access to JDD's full-text articles and archives, upgrade here.

Save an unformatted copy of this article for on-screen viewing.

Print the full-text of article as it appears on the JDD site.

→ proceed | ↑ close

Related Articles